Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025

Core Viewpoint - Catalyst Pharmaceuticals, Inc. will release its first quarter 2025 financial results on May 7, 2025, and will host a conference call and webcast on May 8, 2025, to discuss these results and provide a business update [1][2]. Company Overview - Catalyst Pharmaceuticals is a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients with rare and difficult-to-treat diseases [4]. - The company has a proven track record of bringing life-changing treatments to market and prioritizes patient care through a comprehensive suite of support services [4]. - Catalyst is headquartered in Coral Gables, Florida, and has been recognized on the Forbes 2025 list as one of America's Most Successful Mid-Cap Companies and on the 2024 Deloitte Technology Fast 500™ list as one of North America's Fastest-Growing Companies [4]. Conference Call & Webcast Details - The conference call and webcast will take place on May 8, 2025, at 8:30 AM ET [3]. - US/Canada dial-in number is (833) 316-2483, and the international dial-in number is (785) 838-9284 [3]. - The webcast will be accessible on the company's website, with a replay available for at least 30 days following the event [3].